The Role of Endothelium in COVID-19
The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the risk of a variety of non-pulmonary consequences, t...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/34c75f5d43574dc1910d18ec5aa9026d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:34c75f5d43574dc1910d18ec5aa9026d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:34c75f5d43574dc1910d18ec5aa9026d2021-11-11T17:20:07ZThe Role of Endothelium in COVID-1910.3390/ijms2221119201422-00671661-6596https://doaj.org/article/34c75f5d43574dc1910d18ec5aa9026d2021-11-01T00:00:00Zhttps://www.mdpi.com/1422-0067/22/21/11920https://doaj.org/toc/1661-6596https://doaj.org/toc/1422-0067The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the risk of a variety of non-pulmonary consequences, the most severe and possibly fatal of which are cardiovascular problems. Data show that almost one-third of the patients with a moderate or severe form of COVID-19 had preexisting cardiovascular comorbidities such as diabetes mellitus, obesity, hypertension, heart failure, or coronary artery disease. SARS-CoV2 causes hyper inflammation, hypoxia, apoptosis, and a renin–angiotensin system imbalance in a variety of cell types, primarily endothelial cells. Profound endothelial dysfunction associated with COVID-19 can be the cause of impaired organ perfusion that may generate acute myocardial injury, renal failure, and a procoagulant state resulting in thromboembolic events. We discuss the most recent results on the involvement of endothelial dysfunction in the pathogenesis of COVID-19 in patients with cardiometabolic diseases in this review. We also provide insights on treatments that may reduce the severity of this viral infection.Mihaela IonescuAnca Pantea StoianManfredi RizzoDragos SerbanDomenico NuzzoLaura MaziluAndra Iulia SuceveanuAna Maria DascaluIrinel Raluca ParepaMDPI AGarticleendotheliumSARS-CoV-2COVID-19pathogenesiscomplicationsBiology (General)QH301-705.5ChemistryQD1-999ENInternational Journal of Molecular Sciences, Vol 22, Iss 11920, p 11920 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
endothelium SARS-CoV-2 COVID-19 pathogenesis complications Biology (General) QH301-705.5 Chemistry QD1-999 |
spellingShingle |
endothelium SARS-CoV-2 COVID-19 pathogenesis complications Biology (General) QH301-705.5 Chemistry QD1-999 Mihaela Ionescu Anca Pantea Stoian Manfredi Rizzo Dragos Serban Domenico Nuzzo Laura Mazilu Andra Iulia Suceveanu Ana Maria Dascalu Irinel Raluca Parepa The Role of Endothelium in COVID-19 |
description |
The 2019 novel coronavirus, known as severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) or coronavirus disease 2019 (COVID-19), is causing a global pandemic. The virus primarily affects the upper and lower respiratory tracts and raises the risk of a variety of non-pulmonary consequences, the most severe and possibly fatal of which are cardiovascular problems. Data show that almost one-third of the patients with a moderate or severe form of COVID-19 had preexisting cardiovascular comorbidities such as diabetes mellitus, obesity, hypertension, heart failure, or coronary artery disease. SARS-CoV2 causes hyper inflammation, hypoxia, apoptosis, and a renin–angiotensin system imbalance in a variety of cell types, primarily endothelial cells. Profound endothelial dysfunction associated with COVID-19 can be the cause of impaired organ perfusion that may generate acute myocardial injury, renal failure, and a procoagulant state resulting in thromboembolic events. We discuss the most recent results on the involvement of endothelial dysfunction in the pathogenesis of COVID-19 in patients with cardiometabolic diseases in this review. We also provide insights on treatments that may reduce the severity of this viral infection. |
format |
article |
author |
Mihaela Ionescu Anca Pantea Stoian Manfredi Rizzo Dragos Serban Domenico Nuzzo Laura Mazilu Andra Iulia Suceveanu Ana Maria Dascalu Irinel Raluca Parepa |
author_facet |
Mihaela Ionescu Anca Pantea Stoian Manfredi Rizzo Dragos Serban Domenico Nuzzo Laura Mazilu Andra Iulia Suceveanu Ana Maria Dascalu Irinel Raluca Parepa |
author_sort |
Mihaela Ionescu |
title |
The Role of Endothelium in COVID-19 |
title_short |
The Role of Endothelium in COVID-19 |
title_full |
The Role of Endothelium in COVID-19 |
title_fullStr |
The Role of Endothelium in COVID-19 |
title_full_unstemmed |
The Role of Endothelium in COVID-19 |
title_sort |
role of endothelium in covid-19 |
publisher |
MDPI AG |
publishDate |
2021 |
url |
https://doaj.org/article/34c75f5d43574dc1910d18ec5aa9026d |
work_keys_str_mv |
AT mihaelaionescu theroleofendotheliumincovid19 AT ancapanteastoian theroleofendotheliumincovid19 AT manfredirizzo theroleofendotheliumincovid19 AT dragosserban theroleofendotheliumincovid19 AT domeniconuzzo theroleofendotheliumincovid19 AT lauramazilu theroleofendotheliumincovid19 AT andraiuliasuceveanu theroleofendotheliumincovid19 AT anamariadascalu theroleofendotheliumincovid19 AT irinelralucaparepa theroleofendotheliumincovid19 AT mihaelaionescu roleofendotheliumincovid19 AT ancapanteastoian roleofendotheliumincovid19 AT manfredirizzo roleofendotheliumincovid19 AT dragosserban roleofendotheliumincovid19 AT domeniconuzzo roleofendotheliumincovid19 AT lauramazilu roleofendotheliumincovid19 AT andraiuliasuceveanu roleofendotheliumincovid19 AT anamariadascalu roleofendotheliumincovid19 AT irinelralucaparepa roleofendotheliumincovid19 |
_version_ |
1718432110218313728 |